Herwig Gutzeit
Directeur/Membre du Conseil chez Dresden University of Technology
Profil
Dr. Herwig Gutzeit is Head-Cell Technology & Pharmacology at KINARIS Biomedicals GmbH.
He is on the Board of Directors at Dresden University of Technology.
Dr. Gutzeit was previously employed as a Principal by University of Freiburg.
He received his graduate degree from the University of Oxford and a doctorate degree from the University of Basel.
Postes actifs de Herwig Gutzeit
Sociétés | Poste | Début |
---|---|---|
Dresden University of Technology | Directeur/Membre du Conseil | - |
Anciens postes connus de Herwig Gutzeit
Sociétés | Poste | Fin |
---|---|---|
University of Freiburg | Corporate Officer/Principal | - |
KINARIS Biomedicals GmbH
KINARIS Biomedicals GmbH Pharmaceuticals: MajorHealth Technology KINARIS Biomedicals GmbH develops and manufactures bioactive drugs targeting cellular motor proteins for the therapeutic treatments. It also engages in research, development, and commercialization projects through alliances with biotechnology and pharmaceutical firms. The company was founded by Georgios Tsiavaliaris in 2007 and is headquartered in Dresden, Germany. | Fondateur | - |
Formation de Herwig Gutzeit
University of Oxford | Graduate Degree |
University of Basel | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
KINARIS Biomedicals GmbH
KINARIS Biomedicals GmbH Pharmaceuticals: MajorHealth Technology KINARIS Biomedicals GmbH develops and manufactures bioactive drugs targeting cellular motor proteins for the therapeutic treatments. It also engages in research, development, and commercialization projects through alliances with biotechnology and pharmaceutical firms. The company was founded by Georgios Tsiavaliaris in 2007 and is headquartered in Dresden, Germany. | Health Technology |